Integra Medical expects the acquisition of regenerative tissue product developer ACell to improve its tissue technologies pipeline and accelerate the company’s overall revenue growth.
On 16 December, Integra announced a definitive agreement to acquire ACell for an upfront cash payment of $300m and up to $100m in additional payments tied to revenue growth milestones
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?